Snowball logo
logo
SBFM_logo

Sunshine Biopharma Inc

SBFM โ€ข NASDAQ
$1.15-$0.05ย  (4.17%)
Estimate
EPS
-12.5
Beta
1.31
Growth
Revenue, YoY
-9.13%
Net income, YoY
-5.43%
FCF, YoY
-8.93%
Forecast
P/E (FWD)
5.8
EPS (FWD)
0.2
About the company
Ticker
SBFM
ISIN
US8677814035
Country
Canada
Sector (GICS)
Healthcare
Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, dermatology, smoking cessation, cholelithiasis, anticonvulsant, urology, women's health, acid reflux, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.

Frequently asked questions

What sector does Sunshine Biopharma Inc (SBFM) operate in?

Sunshine Biopharma Inc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Sunshine Biopharma Inc (SBFM) current stock price?

As of the latest data, Sunshine Biopharma Inc stock price is $1.15, with a previous close of $1.20. Sunshine Biopharma Inc lost -$0.05 in the last trading session, representing a -4.17% loss.

What is Sunshine Biopharma Inc (SBFM) current market capitalization?

Sunshine Biopharma Inc market cap is approximately 2.74 million.

What is Sunshine Biopharma Inc (SBFM) Earnings Per Share (EPS)?

The trailing EPS is -$12.50, and the forward EPS is $0.20.

What is Sunshine Biopharma Inc (SBFM) EBITDA?

Sunshine Biopharma Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -1.17 million.

Does Sunshine Biopharma Inc (SBFM) pay dividends?

No. Sunshine Biopharma Inc does not pay a dividend.

How did Sunshine Biopharma Inc (SBFM) perform in its most recent earnings report?

In the last report (March 31, 2026), Sunshine Biopharma Inc posted an EPS surprise of -56.25% and a revenue surprise of -12.08%.

When is Sunshine Biopharma Inc (SBFM) next earnings report?

Sunshine Biopharma Inc is expected to release its next earnings report on June 30, 2026.

What is Sunshine Biopharma Inc (SBFM) beta (volatility) score?

Sunshine Biopharma Inc has a beta of 1.310, suggesting it is more volatile than the market.